Evidence map›Paper›PMID 34061777›Full record

ArticleJCI insight2021

Maternal metabolic health drives mesenchymal stem cell metabolism and infant fat mass at birth.

Melissa L Erickson, Zachary W Patinkin, Allison M Duensing, Dana Dabelea, Leanne M Redman, Kristen E Boyle

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 28 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Beyond Deterministic Fetal Programming: Intrauterine Exposures and the Multifactorial Origins of Adiposity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. 3-D biomechanics and epigenomics reveal atypical fibroblast responses in cardiometabolic disease.American journal of physiology. Heart and circulatory physiology · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Melissa L EricksonPennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA.
Zachary W PatinkinDepartment of Obstetrics and Gynecology, University of Rochester Medical Center, Rochester, New York, USA.
Allison M DuensingDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Dana DabeleaDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Leanne M RedmanPennington Biomedical Research Center, Louisiana State University, Baton Rouge, Louisiana, USA.
Kristen E BoyleDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Pennington Biomedical Research Center · USColorado School of Public Health · USIFB Adiposity Diseases · DEUniversity of Colorado Anschutz Medical Campus · USUniversity of Rochester Medical Center · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
NIH Prior Approval Process ProfessionalUL1TR002535 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2018 to 2022
$51.1M
Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
PILOT STUDY--SUBSTRATE METABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTSP30DK048520 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI JANINE A HIGGINS · 1995 to 2026
$32.6M
Research BaseP30DK072476 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI ROBERT A KESTERSON · 2005 to 2026
$26.5M
The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort StudyUH3OD023248 · OD · UNIVERSITY OF COLORADO DENVER · PI Traci Allison Bekelman, Dana Dabelea · 2018 to 2026
$14.8M
Exploring the Fuel-Mediated Programming of Neonatal GrowthR01DK076648 · NIDDK · UNIVERSITY OF COLORADO DENVER/HSC DENVER · PI DABELEA, DANA · 2009 to 2018
$7.0M
The Early Life Exposome and Childhood Health - The Colorado Healthy Start 3 Cohort StudyUG3OD023248 · OD · UNIVERSITY OF COLORADO DENVER · PI BEKELMAN, TRACI ALLISON, DABELEA, DANA · 2016 to 2024
$5.9M
Training in Obesity ResearchT32DK064584 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI CORBY K MARTIN, Christopher D Morrison · 2003 to 2026
$5.3M
A pragmatic, scalable e-health intervention for management of gestational weight gain in low-income mothersR01NR017644 · NINR · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI REDMAN, LEANNE MAREE · 2019 to 2024
$3.6M
Promoting fat loss during pregnancy in women with grade 2 and 3 obesityR01DK124806 · NIDDK · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI PHELAN, SUZANNE, REDMAN, LEANNE MAREE · 2020 to 2024
$3.2M
Epigenetic programming of infant mesenchymal stem cells: mechanisms for obesity and diabetes risk in humansR01DK117168 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI BOYLE, KRISTEN ELIZABETH · 2018 to 2022
$1.7M
NCATS NIH HHS UL1 TR001082NCATS NIH HHS UL1 TR002535NIDDK NIH HHS P30 DK048520NIDDK NIH HHS P30 DK072476NIDDK NIH HHS R01 DK076648NIDDK NIH HHS R01 DK117168NIDDK NIH HHS R01 DK124806NIDDK NIH HHS T32 DK064584NIGMS NIH HHS U54 GM104940NIH HHS UG3 OD023248NIH HHS UH3 OD023248NINR NIH HHS R01 NR017644
6 · The paper itself

Abstract

Exposure to maternal obesity may promote metabolic dysfunction in offspring. We used infant mesenchymal stem cells (MSCs) to experimentally examine cellular mechanisms of intergenerational health transmission. Our earlier reports show MSCs collected from infants of mothers with obesity had a dichotomous distribution in metabolic efficiency; they were either efficient (Ef-Ob) or inefficient (In-Ob) with respect to fatty acid oxidation (FAO). Here, we sought to determine if this was due to a primary defect in FAO. Accordingly, we measured FAO in myogenic differentiating MSCs under 3 conditions: (a) myogenesis alone, (b) excess fatty acid exposure, and (c) excess fatty acid exposure plus a chemical uncoupler to increase metabolic rate. Compared with normal weight and Ef-Ob MSCs, In-Ob displayed lower FAO in myogenesis alone and after fatty acid plus uncoupler, indicating In-Ob were less metabolically flexible after increasing lipid availability and metabolic rate, demonstrating a primary deficit in FAO. MSC FAO was negatively associated with fasting maternal glucose and insulin and positively associated with fasting HDL-cholesterol. MSC FAO was negatively associated with infant fat mass. These data indicate a less favorable maternal metabolic milieu, independent of maternal BMI, reduces intrinsic MSC FAO and is linked to higher infant adiposity as early as birth.

Indexed as

ObesityPregnancy ComplicationsPrenatal Exposure Delayed EffectsAdiposityBirth WeightFatty AcidsFemaleHumansInfant, NewbornMesenchymal Stem CellsMetabolic Flux AnalysisMetabolic Networks and PathwaysMuscle DevelopmentOxidation-ReductionPregnancyFatty AcidsFatty acid oxidationHuman stem cellsMetabolismObesityReproductive Biology

Identifiers

PMID34061777
PMCPMC8410068
OpenAlexW3164852536

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.